> Nasdaq is warning Oncothyreon that it has to be compliant with capital requirements by September 15 to prevent its move from the Global Market to the Capital Market. Report
> ATS has bought out a majority of the shares of Germany's Ganymed Pharmaceuticals. Ganymed also announced that it is expanding its pipeline of antibodies. Release
> Ablynx announced today that the Alzheimer's disease collaboration with Boehringer Ingelheim was proceeding well and therefore the research funding has been extended for another year. Release
> iBioPharma has closed on a $5 million private placement of common stock and warrants. Release
> Eli Lily has closed its deal to buy SGX Pharmaceuticals. Release
> Would a bigger bid for Genentech just induce more scientists there to exit out the back door as Roche comes in the front? Report
> We know statins lower HDL, or "bad" cholesterol. We also know that they tend to lower LDL, or "good" cholesterol, too. And we suspect that it's possible for low LDL levels to boost the risk of cancer. So, do statins increase the risk of cancer? Report
> GlaxoSmithKline has announced that it will report its grants to U.S. hospitals, CME companies, patient advocacy groups, professional associations and the like. Report
> Are HPV vaccines worth the cost? A study in the New England Journal of Medicine concludes that they aren't--at least not for women over 18. Report
And Finally...